Preferred Label : Aclarubicin Hydrochloride;
NCIt synonyms : (1R,2R,4S)-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-alpha-L-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecarboxylic
acid methyl ester; Aclacinomycin-A; Aclacinomycin; Antibiotic MA144-A1; Aclacinomycin A hydrochloride; Aclarubicin; ACM-A; 1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5, 7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-((2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)
-alpha-L-lyxo-hexopyranosyl]-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy]-, methyl
ester,(1R-(1alpha,2beta,4beta))-(9CI); Aclacinomycin A;
UNII : 501948RI66;
InChIKey : KUSMIBXCRZTVML-PCCPLWKKSA-N;
CAS number : 75443-99-1;
Drug name : Aclacinon; Aclacin; Aclacinomycine; Aclaplastin; Jaclacin;
Molecule name : MA144-A1;
Chemical formula : C42H53NO15.ClH;
Codes from synonyms : NSC0208734;
Origin ID : C95830;
UMLS CUI : C0771002;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
False automatic mappings
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT
concept_is_in_subset
has_free_acid_or_base_form
is_salt_form_of